
AMWL
USDAmerican Well Corporation Class A Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$4.230
Haut
$4.280
Bas
$4.100
Volume
0.21M
Fondamentaux de l'Entreprise
Capitalisation Boursière
67.6M
Industrie
Health Information Services
Pays
United States
Statistiques de Trading
Volume Moyen
0.08M
Bourse
NYQ
Devise
USD
Intervalle sur 52 Semaines
Rapport d'Analyse IA
Dernière mise à jour: 2 nov. 2025AMWL Stock Analysis: American Well at Critical Support Level (November 2025)
Price Action Review
American Well (AMWL) has been in a downward spiral since August 2025, dropping from $7.01 to a 52-week low of $5.13 by October 30th. Key patterns observed:
- 87% crash from August high ($8.65) to October low ($5.13)
- Double-bottom formation at $5.13-$5.15 support zone (Oct 30-Nov 1)
- Volume spikes during decline (149k shares on Oct 10, 106k on Oct 22)
- Recent consolidation around $5.22 after hitting the 52-week low
Fundamental Snapshot
| Metric | Value | Commentary |
|---|---|---|
| Market Cap | $84.3M | Micro-cap stock (high risk) |
| P/E Ratio | -0.68x | "Better" than industry (-1.0x) |
| Return on Equity | -37.6% | Severe profitability issues |
| Debt-to-Equity | 2.17x | Exceeds healthy thresholds |
| Revenue Growth | 12.9% | Modest growth for healthcare tech |
Technical Indicators
- Bullish Breakout Signals
- Price hugging $5.15 support level
- MACD crossover (0.0056 > signal line 0.0001)
- On-Balance Volume surged to 4.7x average
- ADX at 9.2 suggests weak trend strength
- Critical Levels
- Support: $5.11 (recent low)
- Resistance: $5.31 (near take-profit level)
- Stop-loss: $4.69 (9% below entry)
Strategic Guidance
Buy Signal: $5.13-$5.19 range Take Profit: $5.31 (+3.5% target) Stop Loss: $4.69 (-8.5% risk) Hold Period: 1-2 weeks
Setup suggests a potential bounce from historic lows, though with limited upside projection. Traders should consider position sizing no more than 1-2% of portfolio given risk factors.
Risk Considerations
⚠️ Medium-High Risk Profile:
- Low Volatility: Makes breakout confirmation difficult
- Micro-Cap Status: Limited liquidity ($75k average volume)
- Fundamental Weakness: Negative ROE and high debt-to-equity ratio
- 52-week low trade: No margin for error at this support level
Current Outlook
While technicals show classic signs of short-term bottoming (volume surge + MACD crossover), fundamentals remain deeply problematic. The recommendation appears based primarily on bargain-hunting potential at extreme levels rather than business quality.
Given the AI prediction score of 0.0, traders should treat this as a pure technical play rather than fundamentals-driven growth opportunity. The neutral sentiment score and lack of news events suggest price action will be driven by technical factors and broader market conditions.
Action: Consider small-scale entry near $5.13 with strict risk management Timing: Setup valid for 19 more days (through Nov 21) Caution: Negative fundamentals make this a speculative trade
*This analysis is based solely on structured data dated 2025-11-02. Always verify current
Actualités Connexes
Amwell® Announces Results for Third Quarter 2025
BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the third
Prédiction IABeta
Recommandation IA
Mis à jour le: 10 nov. 2025, 15:20
69.0% Confiance
Risque et Trading
Point d'Entrée
$4.15
Prise de Bénéfices
$4.27
Stop Loss
$3.77
Facteurs Clés
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.